CO-INHIBITORY RECEPTORS IN NON-UROTHELIAL BLADDER CANCER-TARGETS FOR NEXT GENERATION IMMUNOTHERAPY

被引：0
|
作者：
Eismann, Lennert
Ledderose, Stephan
Marcon, Julian
Bischoff, Robert
Waidelich, Raphaela
Schulz, Gerald
Casuscelli, Jozefina
Stief, Christian
Rodler, Severin
机构：
来源：
JOURNAL OF UROLOGY | 2024年 / 211卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP65-04
引用
收藏
页码：E1078 / E1078
页数：1
相关论文
共 50 条
  • [31] Pan-cancer analysis of co-inhibitory molecules revealing their potential prognostic and clinical values in immunotherapy
    Ren, Xiaoyu
    Guo, Anjie
    Geng, Jiahui
    Chen, Yuling
    Wang, Xue
    Zhou, Lian
    Shi, Lei
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [32] The Effect of Sex on Disease Stage and Survival after Radical Cystectomy in Non-Urothelial Variant-Histology Bladder Cancer
    Flammia, Rocco Simone
    Tufano, Antonio
    Chierigo, Francesco
    Wurnschimmel, Christoph
    Hoeh, Benedikt
    Sorce, Gabriele
    Tian, Zhen
    Anceschi, Umberto
    Leonardo, Costantino
    Del Giudice, Francesco
    Terrone, Carlo
    Giordano, Antonio
    Morrione, Andrea
    Saad, Fred
    Shariat, Shahrokh F.
    Briganti, Alberto
    Montorsi, Francesco
    Chun, Felix K. H.
    Gallucci, Michele
    Karakiewicz, Pierre I.
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (05)
  • [33] Prognostic significance of non-urothelial carcinoma of bladder: analysis of nationwide hospital-based cancer registry data in Japan
    Nagumo, Yoshiyuki
    Kawai, Koji
    Kojima, Takahiro
    Shiga, Masanobu
    Kojo, Kosuke
    Tanaka, Ken
    Kandori, Shuya
    Kimura, Tomokazu
    Kawahara, Takashi
    Okuyama, Ayako
    Higashi, Takahiro
    Nishiyama, Hiroyuki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 50 (09) : 1068 - 1075
  • [34] Checkpoint-Inhibitors in Lung and Bladder Cancer Next Generation of Cancer Immunotherapy realized with Atezolizumab
    Vetter, Christine
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 (04) : 232 - 232
  • [35] Identification of potential therapeutic targets in urothelial bladder carcinoma of Chinese population by targeted next-generation sequencing
    Wang, Tao
    Liu, Zhengsheng
    Wang, Xuegang
    Bai, Peide
    Sun, Anran
    Shao, Zhiqiang
    Luo, Rongtuan
    Wu, Zhun
    Zhang, Kaiyan
    Li, Wei
    Xiao, Wen
    Duan, Bo
    Wang, Yongfeng
    Chen, Bin
    Xing, Jinchun
    CANCER BIOLOGY & THERAPY, 2020, 21 (08) : 709 - 716
  • [36] Anti-PD-L1-Based Bispecific Antibodies Targeting Co-Inhibitory and Co-Stimulatory Molecules for Cancer Immunotherapy
    Geng, Qiaohong
    Jiao, Peifu
    MOLECULES, 2024, 29 (02):
  • [37] NEXT GENERATION SEQUENCING OF NON-MUSCLE INVASIVE BLADDER CANCER REVEALS POTENTIAL BIOMARKERS AND RATIONAL THERAPEUTIC TARGETS
    Pietzak, Eugene
    Cha, Eugene
    Bagrodia, Aditya
    Drill, Esther
    Iyer, Gopa
    Baez, Priscilla
    Isharwal, Sumit
    Li, Qiang
    Zehir, Ahmet
    Arcila, Maria
    Berger, Michael
    Schultz, Nikolaus
    Ostrovnaya, Irina
    Rosenberg, Jonathan
    Bajorin, Dean
    Dalbagni, Guido
    Al-Ahmadie, Hikmat
    Solit, David
    Bochner, Bernard
    JOURNAL OF UROLOGY, 2017, 197 (04): : E905 - E905
  • [38] Nomograms for predicting the overall and cancer-specific survival in patients with non-urothelial carcinoma of the bladder: A population-based study
    Li, Zhenchi
    Xu, Zhibin
    Wang, Jiangping
    Wang, Mei
    BIOMOLECULES AND BIOMEDICINE, 2024, 24 (03): : 633 - 646
  • [39] Dual targeting of CD137 co-stimulatory and PD-1 co-inhibitory molecules for ovarian cancer immunotherapy
    Wei, Huafeng
    Zhao, Likun
    Hellstrom, Ingegerd
    Hellstrom, Karl Erik
    Guo, Yajun
    ONCOIMMUNOLOGY, 2014, 3 (03)
  • [40] Next generation drugs in urothelial cancer: adenoviruses in the treatment of BCG-unresponsive nonmuscle invasive bladder cancer
    Barth, Dominik A.
    Pichler, Martin
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2023, 16 (03) : 189 - 192
12345